NCT06547502View on ClinicalTrials.gov

Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 3, 2024

Primary Completion Date

August 20, 2024

Study Completion Date

September 5, 2024

Conditions
Diabetes
Interventions
DRUG

GZR4

single dose

Trial Locations (1)

Unknown

Site 1, Suzhou

Sponsors
All Listed Sponsors
lead

Gan and Lee Pharmaceuticals, USA

INDUSTRY

NCT06547502 - Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment | Biotech Hunter | Biotech Hunter